BridgeMD
New treatment option for Rotator Cuff Tear
Official title Research and Clinical Validation of a Wearable Device-Based Remote Rehabilitation System for Postoperative Rotator Cuff Injury
ClinicalTrials.gov ID: NCT07412184
What this study is testing
- What it's testing
- This study included patients who underwent their first shoulder rotator cuff surgery at Peking University Third Hospital, diagnosed with small to medium rotator cuff tears based on MRI results. Participants were randomly divided into an online wearable device training group and an offline traditional rehabilitation group, with 36 individuals in each group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥18 years;
- First-time rotator cuff injury surgery and received surgical treatment at Peking University Third Hospital;
- MRI shows a tear with a maximum diameter \<3 cm, confirmed by at least three musculoskeletal rehabilitation radiologists;
- Possess a mobile device with internet access (e.g., smartphone or tablet) capable of using mobile applications;
- Able to complete the planned study and follow-ups within 6 months after discharge;
You likely can't join if
- Presence of serious cardiovascular or cerebrovascular diseases, or cervical spondylosis with nerve damage;
- Presence of cognitive impairment or vision problems;
- Stroke, rheumatic disease, neurological disorders, or diseases limiting overall physical function or cardiopulmonary function within the past 2 years;
- No prior history of shoulder joint injury, and having undergone other surgeries within the past 6 months;
- Patients who cannot complete the entire cycle or drop out midway;
- Presence of serious postoperative complications, such as wound infection, venous thromboembolism, etc.
See the full eligibility criteria
- Age ≥18 years;
- First-time rotator cuff injury surgery and received surgical treatment at Peking University Third Hospital;
- MRI shows a tear with a maximum diameter \<3 cm, confirmed by at least three musculoskeletal rehabilitation radiologists;
- Possess a mobile device with internet access (e.g., smartphone or tablet) capable of using mobile applications;
- Able to complete the planned study and follow-ups within 6 months after discharge;
- No visual, hearing, cognitive, or communication impairments;
- Able to provide informed and valid consent to participate in the study.
- Presence of serious cardiovascular or cerebrovascular diseases, or cervical spondylosis with nerve damage;
- Presence of cognitive impairment or vision problems;
- Stroke, rheumatic disease, neurological disorders, or diseases limiting overall physical function or cardiopulmonary function within the past 2 years;
- No prior history of shoulder joint injury, and having undergone other surgeries within the past 6 months;
- Patients who cannot complete the entire cycle or drop out midway;
- Presence of serious postoperative complications, such as wound infection, venous thromboembolism, etc.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.